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Objective. To compare the molecular, histological, and functional characteristics of growth hormone (GH)- and pressure overload-
induced cardiac hypertrophy, and their responses to ischemia-reperfusion and mechanical stretch.
Design. Four groups of male Wistar rats were studied: aortic banding (n = 24, AB) or sham (n = 24, controls) for 10 weeks, and GH
treatment (n = 24; 3.5 mg/kg/day, GH) or placebo (n = 24, controls) for 4 weeks. At 13 weeks, the rats were randomly subjected to:
(i) assessment of basal left ventricular mRNA expression of sarcoplasmic reticulum calcium-ATPase (SERCA-2), phospholamban
(PLB), and Na+–Ca2+ exchanger (NCX) and collagen volume fraction (CVF) (Protocol A, 8 rats in each group); (ii) left ventricular
no-ﬂow ischemia with simultaneous evaluation of intracellular Ca2+ handling and ATP, phosphocreatine (PCr) and inorganic phos-
phate (Pi) content (Protocol B, 12 rats in each group); or (iii) left ventricular mechanical stretch for 40 min with assessment of tumor
necrosis-a (TNF-a) mRNA (Protocol C, 4 rats in each group). Protocol B and C were carried out in a Langendorﬀ apparatus.
Results. In Protocol A, no diﬀerence was found as to myocardial mRNA content of Ca2+ regulating proteins and CVF in GH
animals vs controls. In contrast, in the AB group, myocardial mRNA expression of SERCA-2 and PLB was downregulated while
that of NCX and CVF were increased vs. controls (p < 0.05). In Protocol B, recovery of left ventricular function was signiﬁcantly
decreased in AB vs GH groups and controls and this was associated with 1.6-fold increase in intracellular Ca2+ overload during
reperfusion (p < 0.05). Baseline ATP content was similar in the four study groups, whereas PCr and Pi was lower in AB vs GH rats
and controls. However, the time courses of high-energy phosphate metabolic changes did not diﬀer during ischemia and reperfusion
in the four study groups. In Protocol C, no detectable TNF-a mRNA level was found in the left ventricular myocardium of GH
treated rats and controls at baseline, while a modest expression was noted in AB animals. Mechanical stretch resulted in de novo
myocardial TNF-a mRNA expression in GH group and controls, which was dramatically increased in AB animals (5-fold above
baseline, p < 0.001).1096-6374/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.ghir.2005.09.002
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ARTICLE IN PRESSConclusions. The data show that cardiac hypertrophy activated by short-term GH treatment confers cardioprotection compared
with pressure overload with regard to molecular and histological characteristics, and responses to ischemia-reperfusion and mechan-
ical stretch.
 2005 Elsevier Ltd. All rights reserved.
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Augmenting muscles mass is one of the means by
which the heart faces a hemodynamic burden, in addi-
tion to the recruitment of neurohormonal mechanisms
and the use of the Frank–Starling mechanism [1]. How-
ever, load-induced hypertrophy (pathologic hypertrophy)
is characterized by interstitial ﬁbrosis, molecular remod-
eling with reduced sarcoplasmic reticulum and increase
of sarcolemmal content of Ca2+ regulating proteins,
and progressive cell death [2]. Several studies have doc-
umented that post-ischemic recovery of mechanical
function is impaired in load-induced hypertrophy
[3–6]. However, little data is available with regard to
the pathophysiological mechanisms of such impaired
recovery, particularly its dependency on perturbations
of intracellular Ca2+ handling and/or energy metabo-
lism, nor myocardial TNF-a expression has been tested
in response to acute mechanical stretch in hypertrophied
hearts.
On the other hand, myocardial growth stimulated by
the activation of the growth hormone/insulin-like
growth factor I (GH/IGF-I) axis appears more ‘‘physio-
logic’’ than load-induced hypertrophy, at least in the
short-term, insofar as it is associated with unchanged
capillary density, no interstitial remodeling, normal or
even augmented systolic and diastolic function, and re-
duced apoptotic rate [7,8]. Such observations have
prompted several experimental investigations focused
on GH/IGF-I activation in heart failure by genetic
manipulation or pharmacological means [8–11].
However, no study has compared vis-a`-vis the molec-
ular and histological characteristics of GH- and load-
induced hypertrophy. In addition, there is no information
as to whether these two kinds of hypertrophy entail dif-
ferent responses to ischemic and mechanical injury. The
current study was performed to clarify these issues using
classical models of ischemia-reperfusion and mechanical
stretch in vitro.2. Methods
The investigation conforms with the Guide for the
Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication
No. 85-23, revised 1996), and experimental procedures
were approved by the local Animal Care Committee.Wistar rats of male sex were used and the study design
is shown in Fig. 1. Transverse banding of ascending aor-
ta (AB) was performed placing a tantalum hemoclip in
rats aged 3 weeks, as previously described [12]. Sham
rats underwent the same surgical procedures, although
the clip was not placed. Growth hormone treatment
(3.5 mg/kg body weight rhGH per day via two subcuta-
neous injections) or placebo (normal saline) were ran-
domly started in rats aged 9 weeks and continued for
4 weeks. Ex vivo studies were performed at 13 weeks
of age. No death was observed during surgery and be-
fore the ﬁnal experiments. Timing of AB and GH treat-
ment, and even more GH dosage, were established on
the basis of pilot experiments (unpublished data) show-
ing that at 13 weeks of age, AB and GH-treated rats
achieved similar D left ventricular growth responses
(see below).
2.1. Assessment of cardiac growth in AB and GH-treated
rats
Although the optimal method for comparing heart
weights in the rat is unknown, normalizing left ventric-
ular weight to tibial length relates cardiac size to the
amount of lean body tissue and to cell size more than
does normalization to body weight [13]. Accordingly,
at the end of the ﬁnal experiments, right hind legs of
the rats were removed by disarticulating the femurs
from the acetabulum at the hip. The tibias were dis-
sected free of soft tissue and frozen at 20 C. Four
radiographic ﬁlms (X-Omat XTL2, Eastman Kodak
Co) of the tibias were then obtained, and the tibial
length of each animal was assessed with a caliper from
the radiograph.
2.2. Protocol A
A total of 32 hearts (n = 8 in each group) underwent
basal molecular analysis and histochemistry. Immedi-
ately after rats were sacriﬁced, left ventricles were care-
fully separated form right ventricles and stored for
subsequent analysis.
2.2.1. Basal myocardial mRNA expression of Ca2+
regulating proteins (n = 4 in each group)
Total RNA was prepared from left ventricular myo-
cardium according to the method of Chomczynski
et al., as previously described [14]. For sarcoplasmic
Fig. 1. Study design. AB = aortic banding; GH = growth hormone.
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ARTICLE IN PRESSreticulum calcium-ATPase (SERCA-2), Na–Ca2+ ex-
changer (NCX) and phospholamban (PLB), the poly-
merase chain reaction products which were 523, 429
and 535 bp respectively, were cloned into a Bluescript
vector. They were subsequently transformed into com-
petent bacteria which where selected and sequenced
using the Big Dye TM terminator cycle sequencing kit
(ABI Prism, PE Applied Biosystems, Warrington,
UK). RNAse protection assay (RPA II kit Ambion)
and the solution hybridization RNAse protection assay
were performed according to the manufacturers instruc-
tions with 20 lg of total RNA, prepared as previously
described [14].2.2.2. Collagen volume fraction (n = 4 in each group)
The whole left ventricles were cut serially into 10–14
transverse sections (varying according to the hearts size)
1 mm thick each, from apex to base. Six lm thick trans-
verse sections were subsequently stained with Picrosirius
red. Slides were observed with a Nikon Microphot FXA
light microscope equipped with a polarized set and ana-
lysed with Zeiss KS300 software. Collagen volume frac-
tion (CVF) was expressed as the mean percentage of
connective tissue areas divided by total tissue area in
the same ﬁeld [15].2.3. Isolated whole heart preparation
A total of 64 rats (n = 16 in each group), underwent
isolated whole heart preparation protocol (Fig. 1, Proto-col B and C). Under deep anesthesia, hearts were rapidly
excised and immersed in ice-cold Krebs–Henseleit buf-
fer, weighted and mounted in a Langendorﬀ apparatus
at a constant temperature of 37 C, as previously de-
scribed [16–19]. Perfusion was set at a constant ﬂow of
12 ml/min per gram of heart weight by means of a roller
pump using phosphate-free, Krebs–Henseleit buﬀer
(118 mmol/l NaCl, 4.7 mmol/l KCl, 1.75 mmol/l CaCl2,
1.2 mmol/l MgSO4, 0.5 mmol/l EDTA, 25 mmol/l NaH-
CO3, 11 mmol/l glucose), which was inline ﬁltered (45
lm pore size) and bubbled with 95% O2 and 5% CO2
to yield a pH of 7.4; coronary perfusion pressure was
measured with a Statham P23Db transducer (Gould
Instruments, Oxnard, CA, USA) connected to the perfu-
sion line. To calculate the coronary ﬂow, the total eﬄu-
ent was collected intermittently in a calibrated cylinder
over a time period of 1 min. Cardiac temperature was
measured by a temperature probe inserted into the right
ventricle and was kept constant within ±0.1 C by regu-
lating the temperature of the perfusate. Left ventricular
mechanical performance was continuously measured
with a water-ﬁlled latex balloon inserted into the left
ventricle through an incision in the left atrial appendage,
via the mitral valve, and secured by a ligature. The bal-
loon was attached to a stiﬀ plastic tube and connected to
a Statham P23Db pressure transducer (Gould Instru-
ments, Oxnard, CA, USA) for continuous measurement
of isovolumic pressure. The hearts were paced at 5 Hz
using monophasic square-wave pulses delivered from a
Grass Stimulator (model S 88 S1U5) and two pericardial
electrodes on the free wall of the right ventricle. Left
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curves were digitized using a commercially available
computer. In order to achieve comparable loading con-
ditions (i.e., balloon volumes) in hearts of diﬀerent sizes
and geometry, the left ventricular parameter of interest
was acquired with the intraventricular balloon inﬂated
at 50% of the volume that resulted in the maximum left
ventricular developed pressure (50% of Volmax), as pre-
viously validated [18]. Left ventricular wall stress (r)
and relative wall thickness (hr) were derived from left
ventricular pressure measurements, intraventricular bal-
loon volume, and weight of left ventricle as previously
described [18].2.4. Protocol B
A total of 48 hearts (n = 12 in each group), under-
went ischemia-reperfusion protocol with assessment of
intracellular Ca2+ handling and high-energy phosphate
metabolism. After an equilibration period of 15 min at
50% of Volmax, the perfusion line was clamped (no-ﬂow
ischemia) and hearts were subjected to global normo-
thermic ischemia for 20 min followed by 30 min of
reperfusion. Half of the hearts in each group were stud-
ied in the Ca2+-setup, the other half in the 31P-NMR
setup.2.4.1. Aequorin loading and quantiﬁcation of intracellular
Ca2+ (n = 6 in each group)
Intracellular Ca2+[Ca2+]i was measured in parallel
experiments by aequorin normalized by fractional lumi-
nescence as described below [17,19]. After stabilization
for 10 min at 25 C, 3–5 ll of an aequorin-containing
solution (1 lg/ml) were injected with a glass micropipette
into the interstitium of the inferoapical region of the left
ventricle. The heart was positioned in an organ bath with
the aequorin-loaded area of the left ventricle directed to-
wards the cathode of a photomultiplier (model 9635QA,
Thorn-EMI, Gencom, Inc., Fairfeld, NJ, USA) and sub-
merged in Krebs–Henseleit solution. Subsequently, the
temperature was increased to 37 C within 10 min and
kept constant. Aequorin light signals were recorded on
the 4-channel recorder (Graphtec, Seefeld 82229, Ger-
many), digitized by a 12 bit analog-digital converting
board at a sampling rate of 1 kHz (DAP 800/3, Micro-
star, Bellevue, WA, USA) and stored on the hard drive
of a computer (PC 133 MHz). Normalization of aequo-
rin light signals and analysis of calcium-overload in the
ﬁrst minute of reperfusion was performed as previously
described [17,19]. Speciﬁcally, the following parameters
were used: [Ca2+]isch = end-ischemic [Ca
2+]i, peak = ini-
tial peak of Ca2+ signal in the ﬁrst minute of reperfusion,
Oscillsys = maximum of the ﬁrst 10 transients of Ca
2+
oscillations in the ﬁrst minute of reperfusion (absolute
value), I(060) = time integral of aequorin light signalfrom the beginning until 60 s of reperfusion, normalized
by Lmax [19]. A representative tracing showing an origi-
nal pressure and light signals and the ﬁrst 30 s of reper-
fusion is depicted in Fig. 2.2.4.2. 31P-NMR Spectroscopy (n = 6 in each group)
High-energy phosphates were measured by 31P nu-
clear magnetic resonance (31P-NMR) on a 7 T Bruker
AM system, as previously described [16]. Data were
averaged over 5 min time intervals with 4 K data
points, 152 scans, TR = 1.93 s. Peak amplitudes were
corrected for partial saturation (8% for Pi, 12% for
PCr) by comparing to fully relaxed spectra. The con-
centration of the gamma ATP in control hearts was
set to 10.8 mM [16] and normalized to the heart weight
to obtain the relation between spectrometer intensities
and absolute concentrations [20]. Concentrations of all
other compounds were computed using this factor,
taking into account the heart weight of each individual
heart. Intracellular pH (pHi) was measured by compar-
ing the chemical shift, d, between inorganic phosphate
(Pi) and phosphocreatine (PCr) to values obtained
from a standard curve.2.5. Protocol C
A total of 16 hearts (n = 4 in each group), under-
went mechanical stretch protocol with assessment of
stretch-induced myocardial tumor necrosis-a (TNF-a)
mRNA expression. After 15–30 min at 25 C, the tem-
perature was gradually increased to 37 C and kept
constant. After 15 min stabilization period, the balloon
was further inﬂated to achieve 50% (control un-
stretched myocardium) or 140% of Volmax (severe
stretch), corresponding in controls hearts to a diastolic
pressure of 5–10 and 35–40 mmHg, respectively [21].
This was done to compare hearts of diﬀerent size at
similar preload levels, insofar as it is well known that
load-induced hypertrophy is accompanied by elevated
left ventricular chamber stiﬀness, and therefore choos-
ing the same value of left ventricular diastolic pressure
in controls and AB would have resulted in a signiﬁ-
cant understretching of AB hearts [18]. At 10 min
intervals during experiments, a sample of the coronary
venous eﬄuent was collected in a calibrated cylinder
over a period of 1 min for measuring the lactate pro-
duction (Lactate Reagent; Sigma Chemical Co.). After
40 min, respectively, the balloon was rapidly deﬂated
to a volume just enough to obtain a pressure signal.
After 5 min stabilization, perfusion was terminated
and left ventricles, carefully separated from right ven-
tricles, were quickly frozen in liquid nitrogen. Total
RNA was extracted from homogenized left ventricular
myocardium and Northern analysis was performed as
previously described in details [21].
Fig. 2. Original tracing (upper panel) from a control heart showing coronary perfusion pressure (CPP), left ventricular pressure (LVP) and aequorin
light signal normalized to Lmax (L/Lmax), where control is representative of sham and placebo rats. The lower panel depicts the ﬁrst 30 s of
reperfusion at an enlarged time scale. Note that reperfusion peaks consists of a sequence of Ca2+ transients, a phenomenon known as ‘‘Ca2+-
oscillations’’.
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ARTICLE IN PRESS2.6. Statistical analysis
All data are presented as mean ± SEM. For statisti-
cal comparison among the various groups of hearts
the multiple comparison factorial-one factor ANOVA
was used. Signiﬁcant diﬀerences were detected using
the Neuman–Keuls test. A p values of <0.05 were con-
sidered signiﬁcant.3. Results
3.1. Characteristics of cardiac growth
AB and GH rats had a similar left ventricular concen-
tric hypertrophy, as shown by a comparable values of
both left ventricular to tibial length ratio and thickness
to radius ratio, indicating similar myocardial growth re-sponses in AB and GH groups (Table 1). Molecular
analysis of left ventricular myocardial mRNA expres-
sion of SERCA-2, PLB and NCX revealed signiﬁcant
changes in the AB group, consistent with pathologic car-
diac remodeling, while in the GH group message levels
of the above calcium regulating proteins were unaﬀected
(Table 1). In addition, left ventricular myocardial CVF
was signiﬁcantly increased in AB, while in the GH-
treated animals it was unchanged (Fig. 3). Myocyte area
was slightly but not signiﬁcantly increased in AB and
GH rats (not shown).
3.2. Mechanical performance, calcium handling and
high-energy phosphate metabolism
Data on baseline left ventricular mechanical perfor-
mance are shown in Table 2. Developed pressure was sig-
niﬁcantly increased in the hypertrophied compared with
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ARTICLE IN PRESScontrol hearts. However, developed wall stress, an index
which normalizes pressure to left ventricular weight and
geometry, was not signiﬁcantly diﬀerent among the three
groups, indicating similar left ventricular intrinsic con-
tractility. While in GH treated rats there was no evidence
of diastolic impairment, in pressure-overloaded animals
end-diastolic pressure, time to 90% relaxation, and Tau
at 50% of Vmax were signiﬁcantly higher compared with
controls. The perfusion pressure in the GH and control
group was 80 ± 2 (mean ± SE) and 81 ± 4 mmHg,
respectively, while in AB group it was 98 ± 5 mmHg.
During baseline perfusion, the Ca2+ transients were not
signiﬁcantly diﬀerent among the three groups; however,
there was a tendency to a prolonged Ca2+ transient in
the AB group, which did not come out statistically signif-
icant (Fig. 4). After the onset of global ischemia, hearts
stopped beating within 2 min. During ischemia, contrac-
ture started after approximately 10 min in all groups
and end-diastolic pressure showed the well-described
overshoot upon reperfusion (Fig. 5). Recovery of devel-
oped and end-diastolic pressures were both markedly al-
tered in the AB group, compared with GH and control
hearts (Fig. 5). Heart rate was similar in all groups during
the ischemia protocol.
Quantitative high energy phosphate data from the
whole experimental protocol are depicted in Table 2
and Fig. 5. Under baseline perfusion, PCr content was
lower in the AB group and Pi was increased compared
with the control group, whereas ATP was similar. GH
treated rats exhibited no diﬀerences regarding ATP,
PCr or Pi as compared with controls, but had lower
PCr and Pi content than AB rats. No diﬀerences in intra-
cellular pH were evident during baseline perfusion
among the three study groups. PCr fell rapidly below
20% of its baseline value within 5 min and was undetect-
able after 15 min of ischemia. Pi started to increase sev-
eral fold to values as high as 25 mM at the end of
ischemia. ATP decreased to about 2 mM after 15 min
of ischemia, however, the time course was slower than
that of the PCr decrease. The time courses of metabolic
changes did not diﬀer during ischemia among the three
study groups. Intracellular pH fell to 6.0 at the end of
ischemia and recovered during reperfusion within
5 min to control values in all groups. Post-ischemic
recovery of PCr as percentage of the pre-ischemic value
was similar (about 70%) in all groups, although absolute
PCr content was reduced in the AB group (Fig. 5). ATP
recovered to the same extent in control, AB, and GH
groups; (40 ± 5, 39 ± 3, and 34 ± 6%, respectively) and
Pi decreased, but remained elevated to about 350% of
pre-ischemic values. Maximal intracellular Ca2+ over-
load occurring in the ﬁrst minute of reperfusion as de-
ﬁned by Oscillsys showed a 1.6-fold increase in the AB
hearts (Fig. 6). [Ca2+] at the end of ischemia, peak
[Ca2+] or integrated light emission during the ﬁrst minute
of reperfusion showed no diﬀerences between groups.
Fig. 3. Left ventricular collagen deposition stained with picrosirius red in control, aortic banding (AB) and growth hormone (GH) group, where
control is representative of sham and placebo rats. Note the marked increase of the collagen framework surrounding cardiomyocytes in the group
subjected to AB.
Table 2
Left ventricular mechanical performance and high energy phosphate metabolism during baseline perfusion
dP (mmHg) dr (kdynes/cm2) ed-P (mmHg) T90R (ms) Tau (ms) ATP (mmol/L) PCr (mmol/L) Pi (mmol/L) pHi
N 12 12 12 12 12 12 12 12 12
Sham 86 ± 5 29 ± 3 8 ± 1 77 ± 5 39 ± 5 10.6 ± 0.2 14.4 ± 0.6 2.7 ± 0.3 7.1 ± 0.01
AB 117 ± 2* 28 ± 2 13 ± 2* 94 ± 4* 52 ± 2* 10.3 ± 0.6 11.9 ± 0.9* 4.8 ± 0.7* 7.1 ± 0.01
N 12 12 12 12 12 12 12 12 12
Placebo 89 ± 2 27 ± 1 6 ± 2 72 ± 3 41 ± 2 10.1 ± 0.7 14.9 ± 0.2 2.4 ± 0.5 7.1 ± 0.02
GH 110 ± 3* 31 ± 1 6 ± 1** 71 ± 3** 39 ± 3** 11.1 ± 0.5 15.3 ± 0.6** 2.6 ± 0.4** 7.1 ± 0.01
Data are mean ± SEM; N = number of animal considered for each variable; AB = aortic banding; GH = growth hormone; dP = developed pres-
sure; dr = developed wall stress; ed-P = end-diastolic pressure; T90R = time to 90% relaxation; PCr = phosphocreatine; Pi = inorganic phosphate.
* p < 0.05 vs. sham and placebo.
** p < 0.05 vs. AB.
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ARTICLE IN PRESS3.3. Stretching protocol
Under basal conditions, no myocardial TNF-a
mRNA expression was found in control and GH left
ventricles, whereas detectable TNF-a message levels
were noted in myocardium from pressure-overloaded
animals (Fig. 7). No change in basal myocardial TNF-
a mRNA expression was noted during perfusion with
maintenance of the uninﬂated balloon (5 mmHg left
ventricular end-diastolic pressure). On the contrary,
myocardial stretch at 140% of Vmax, corresponding to
a diastolic pressure of 40 mmHg in controls and GH
animals, and to 63 mmHg in the AB group, was associ-
ated with de novo myocardial TNF-a expression in both
controls and GH hearts, with a further and remarkable
increase in TNF-a transcript levels in hypertrophied
hearts subjected to AB (5-fold vs. baseline; p < 0.001,
Fig. 7). No lactate production was found in the coro-
nary venous eﬄuent during or after 40 min of stretch
(data not shown).4. Discussion
The main ﬁndings of the current study are: (i) patho-
logic left ventricular hypertrophy induced by pressure
overload is characterized by increased collagen volume
fraction, diastolic dysfunction, signiﬁcant changes inthe myocardial mRNA expression of key Ca2+ regulat-
ing proteins, and greater vulnerability to ischemia-reper-
fusion injury and mechanical stretch compared with
normal hearts; (ii) by contrast, GH-induced myocardial
growth appears to be substantially diﬀerent in nature
insofar as is not associated with ﬁbrosis and changes
in Ca2+ regulating proteins, and diastolic function is
preserved. Importantly, the susceptibility to ischemia-
reperfusion and mechanical stretch in vitro is not signif-
icantly altered by GH-induced myocardial growth. The
data support the concept that this kind of growth is
not detrimental but rather confers cardioprotection
against ischemic and mechanical injury compared with
pressure-overload hypertrophy.
4.1. Current study
The current study provides a potential explanation
for the altered post-ischemic recovery of left ventricular
function in load induced hypertrophy. Indeed, direct
measurement of intracellular Ca2+ showed a marked in-
crease of Ca2+ overload in AB hearts upon reperfusion.
Oscillsys reﬂects the amount of Ca
2+ released by the
overloaded sarcoplasmic reticulum on top of the cyto-
solic Ca2+-overload, and are likely generated by rapid
Ca2+ release and re-uptake by the sarcoplasmic
reticulum since inhibitors of the sarcoplasmic reticulum
abolishes them [19]. Ca2+ oscillations in turn are known
Fig. 4. Representative signal averaged Ca2+ transients (upper panel)
and corresponding mechanical contractions (lower panel) of sham,
growth hormone treated (GH) and hearts with hypertrophy due to
aortic banding (AB), where sham is also representative of placebo rats.
Pressure development is similarly increased in both hypertrophy
groups compared to sham. Diastolic function is impaired in AB but
not in GH rats. The Ca2+ transients were not signiﬁcantly diﬀerent,
however there was a tendency of a Ca2+ transient prolongation in the
AB group.
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lar ﬁbrillation and myocardial dysfunction.
Impaired myocardial high energy phosphate metabo-
lism was also explored as an alternative potential culprit
of the increased post-ischemic left ventricular dysfunc-
tion. However, this mechanism appears unlikely, given
the similar time-course and percent recovery of PCr,
ATP, and Pi content among the three study groups,
despite baseline diﬀerences. The negative impact ofload-induced hypertrophy on the myocardium is further
supported by the stretching experiments. Myocardial
TNF-a mRNA was already detectable under baseline
conditions in the AB group, at variance with GH-trea-
ted and control animals. Moreover, its upregulation in
response to mechanical stretch was much more marked
than that occurring in the other study groups. This ﬁnd-
ing bears relevant implications in view of the important
role that TNF-a appears to play in the pathogenesis of
heart failure. Indeed TNF-a stimulates myocyte apopto-
sis, decreases contractility, and disrupts the extracellular
matrix via the activation of metalloproteases [22,23].
Contrary to the situation with pressure overload
hypertrophy, the current study supports the notion that
GH-induced myocardial growth displays unique physio-
logic features. Indeed, not only was the extracellular ma-
trix integrity maintained in GH treated rats and no
changes were observed in candidate Ca2+ regulating
genes, but also the susceptibility to ischemia-reperfusion
injury and mechanical stretch was similar to normal
hearts.
4.2. Comparison with previous studies
Left ventricular hypertrophy induced by chronic
hemodynamic overload is commonly accompanied by
ﬁbrosis, decreased capillary density, and decreased en-
ergy reserve for use under stress situations [2,20]. In
addition, hypertrophic hearts exhibit an impaired func-
tional recovery from ischemia-reperfusion injury [3–6].
Allard et al. have suggested the possibility that Ca2+
overload may be augmented during reperfusion,
although no direct measure of intracellular Ca2+ was
provided in that study [3]. As to myocardial metabolism,
our ﬁndings of decreased PCr during baseline perfusion
are in agreement with those reported by Tian et al., who
found the energy reserve to be decreased during baseline
perfusion in hearts with pressure overload hypertrophy
[20]. No data concerning high energy phosphate metab-
olism after global ischemia was reported in that study.
On the contrary, despite signiﬁcant hypertrophy, GH
treated hearts displayed indices of high energy phos-
phate metabolism not diﬀerent from control hearts.
Such favorable energetic proﬁle was described originally
by Mercadiers group, who proposed an increased num-
ber of active cross-bridges despite a reduced cross-bridge
cycling velocity, typical of V3 isomyosin, in hearts sub-
jected to chronic GH hypersecretion [24].
Early upregulation of the TNF-a activity has been
consistently documented within the stressed
myocardium after persistent mechanical stimulation in
end-stage human heart failure and after experimental
load-induced hypertrophy, and in myocardial infarction
[22,23,25]. In particular, myocardial generation of TNF-
a following mechanical stress was recently characterized
by our group in the same model system, showing that it
Fig. 5. Mechanical function and high energy phosphate metabolism in the sham, aortic banding (AB) and growth hormone (GH) group, where sham
is also representative of placebo rats. Note the decreased post-ischemic recovery of left ventricular function and the higher end-diastolic pressure in
the aortic banding (AB) group (upper panels). PCr content was decreased at baseline and reperfusion in the banded animals, but percent recovery is
similar in all groups (lower left panel). ATP baseline diﬀerences were not evident upon reperfusion (lower right panel). * p < 0.05 vs. sham;  p < 0.05
vs. GH.
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normal circumstances [21]. Conversely, graded mechan-
ical stretch resulted in a progressive increase in TNF-a
mRNA and protein levels. No data were available as
to TNF-a in an already hypertrophic myocardium.
Interestingly, the fact that myocardial TNF-a mRNA
expression was remarkably upregulated in response to
severe mechanical stretch suggests that load-induced
myocardial hypertrophy has an increased susceptibility
to hemodynamic challenges, which may promote and
sustain the transition towards the heart failure
phenotype.
In the short-term, GH-induced left ventricular
hypertrophy is characterized by unchanged capillary
density, absence of interstitial ﬁbrosis, and normal dia-
stolic function, a picture supported by both animaland human studies [7,26,27]. By contrast, in the
long-term GH hypersecretion is associated with the
typical stigmata of acromegalic cardiomyopathy, i.e.
marked left ventricular enlargement, impaired systolic
and diastolic function, and interstitial ﬁbrosis [28]. Ta-
ken together, our ﬁndings lend further support to the
hypothesis that, in the short-term, GH/IGF-1 axis
activation induces a unique type of myocardial re-
sponse that shares many features with physiological
growth.
Our data are in agreement and expand on those re-
ported by Ross Jr.s group, showing that exogenous
GH/IGF-1 in mice produce cardiac hypertrophy and a
positive inotropic eﬀect without causing signiﬁcant
changes in expression of fetal and other selected myo-
cardial genes [29].
Fig. 6. Indices of Ca2+ overload (see Section 2 for details) in the ﬁrst
minute of reperfusion in control, aortic banding (AB) and growth
hormone (GH) group, where control is representative of sham and
placebo rats. The ﬁrst 10 systolic Ca2+ oscillations were increased 1.6-
fold in the aortic banding (AB) group vs. controls. * p < 0.05 vs.
controls;  p < 0.05 vs. GH.
Fig. 7. Representative Northern blot and densitometric analysis of
autoradiographic bands, expressed as mean ± SEM, for TNF-a
expression in unstretched (50% of Volmax) and severely stretched
(140% of Volmax) myocardium from controls (n = 8), growth hormone
(GH, n = 4) and aortic banding (AB, n = 4) rats, where control is
representative of sham and placebo rats. Twenty-ﬁve micrograms of
total RNA was loaded for each lane. Probe control lane refers to
endotoxin-stimulated (10 lg/mL for 8 h) rat macrophage cells. Fold-
induction was referred to an arbitrary number, deﬁned as 1, assigned
to the level of expression estimated in severely stretched myocardium
from control rats. Note the mechanical stretch-induced de novo
myocardial TNF-a mRNA expression in GH group and controls,
which was dramatically increased in AB animals. * p < 0.001 vs. the
corresponding stretched groups;  p < 0.001 vs. the corresponding
unstretched myocardium.
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ARTICLE IN PRESS4.3. Pathophysiological and clinical implications
The current study provides two mechanisms poten-
tially responsible for the poor outcome of pathologic left
ventricular hypertrophy, namely intracellular Ca2+
overload during ischemia and enhanced stretch-induced
myocardial TNF-a expression. Not only is this
particular type of myocardial growth characterized by
increased ﬁbrosis, reduced capillary density, re-expres-
sion of the embryonic gene program, but it is also par-
ticularly susceptible to frequently occurring challenges.
In the clinical scenario, repetitive episodes of ischemia
may often occur in hypertrophied hearts, as well as sud-
den left ventricular mechanical stretch due to hyperten-
sive bursts, or a combination thereof. Such events, by
increasing intracellular Ca2+ overload and TNF-a myo-
cardial production, may induce lethal ventricular
arrhythmias and accelerate the transition to heart
failure.
It is controversial whether reactivation of cardiac
growth may be beneﬁcial in heart failure. Recent studies
using molecular techniques have shown that inhibiting
myocardial growth by genetic manipulation, such as
blocking Gaq or RAS signaling prevents cardiac dys-
function despite increased wall stress [30,31]. Con-
versely, stimulation of cardiac growth, particularly
when oriented toward concentric remodeling, by activa-
tion of ERK, telomerase reverse transcriptase, or inhibi-
tion of nitric oxide synthesis appears to protect from
cardiac decompensation in similar models of pressure
overload [32]. The current data point to the existence
of peculiar types of ‘‘physiologic’’ myocardial growth
that may be beneﬁcial in the setting of cardiac remodel-
ing given the striking diﬀerences with pressure overload
hypertrophy. In this regard, GH-induced myocardialgrowth also stimulates survival pathways, as recently
suggested by two studies in the rat model of post-infarc-
tion heart failure [15,33]. The complex intracellular sig-
naling involved in these such salutary actions is under
active investigations and possibly involves Akt, a speciﬁc
substrate of IGF-I positioned downstream of PI3-kinase
[34]. In fact, relevant to the current study, Akt-induced
hypertrophy is associated with a positive inotropic eﬀect
without re-expression of the fetal gene program and
p44/42 MAPK activation in vivo, at variance with
stress-induced pathologic hypertrophy [34]. In addition,
more recently, McMullen et al. have shown that trans-
genic mice overexpressing IGF-1 receptor in the heart
displayed compensated cardiac hypertrophy, character-
ized by increased myocyte size with no evidence of histo-
pathology and enhanced systolic function over time,
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PI3-kinase/Akt-p70S6K1 pathway [35].Acknowledgements
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